Delivery Order SPE2DB20D2104-SPE2DB25FMYWW
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,696.20 on May 20, 2025, for the supply of Advair 500-50 Diskus inhalers (60-count units). This firm fixed-price delivery order, with an ultimate completion date of May 21, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical prime vendor agreement with DLA Troop Support Medical. The award was competitively made with no set-aside designation, and the place of...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Advair 115 mcg 12 gm inhalers with a firm fixed price of $1,829.89. The contract is non-set-aside and competitively awarded, with performance to be completed by September 30, 2025, at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) vehicle, the DLA Troop...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Advair 115mcg 12gm inhalers at a firm fixed price of $2,429.57, with completion scheduled for June 20, 2025. This competitively awarded, non-set-aside contract represents a child delivery order executed under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order valued at $1,819.65 to AmerisourceBergen Drug Corp for the supply of Advair 500-50 Diskus 60-count inhalers on September 18, 2025, with completion scheduled for September 19, 2025. This competitively awarded, firm fixed-price delivery order represents a direct procurement of pharmaceutical products to support federal medical supply requirements. The award was issued to AmerisourceBergen's Corporate Office located in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $2,097.68 on April 30, 2025, for the supply of Advair 250-50 Diskus 60 count inhalers, with completion scheduled for May 1, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Advair HFA 230/21 microgram inhalers in 12-gram units, with a contract ceiling value of $1,608.05. This firm fixed-price delivery order, which is due for completion by August 29, 2025, represents a non-competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The pharmaceutical product will...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm) valued at $4,403.25. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to conclude by August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a $5,167.20 delivery order to AmerisourceBergen Drug Corp for Advair 500-50 Diskus inhalers (60-count units) on May 28, 2025, with completion scheduled for May 29, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, was selected to...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for Advair 230-21 micrograms inhalers valued at $15,927.56 under a firm fixed-price contract. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. The contract was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm) valued at $2,091.24. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYWWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Advair 500-50 Diskus inhalers (60-count units) under a firm fixed-price contract valued at $1,376.10. This non-set-aside competitive award represents a child contract issued against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The delivery order is scheduled for completion by August 27, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, supplies a comprehensive range of medications and medical supplies to military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order for the respiratory medication Advair exemplifies the company's role in fulfilling federal medical procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. The award underscores AmerisourceBergen's position as a primary vendor capable of meeting federal competition requirements and supporting military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/26/25 |